Stockreport

BridgeBio Pharma Inc (BBIO) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid Rising ... [Yahoo! Finance]

BridgeBio Pharma, Inc.  (BBIO) 
Last bridgebio pharma, inc. earnings: 3/2 08:29 am Check Earnings Report
PDF Royalty Revenue: $4.3 million from ex-US net sales of Beyonttra in Europe and Japan. License and Services Revenue: $8.3 million. Operating Expenses: $259.3 million, [Read more]